Background: Diabetic kidney disease (DKD) is the most common cause of the end-stage
renal disease (ESRD). Regardless of intensive treatments with hyperglycemic control, blood …

Acute kidney injury (AKI), previously termed acute renal failure, is associated with increased
mortality, prolonged hospital stay, and accelerated chronic kidney disease (CKD). Over the …

Hypertension, a global public health problem, is currently the leading factor in the global
burden of disease. It is the major modifiable risk factor for heart disease, stroke and kidney …

Background The advantages of angiotensin-converting enzyme inhibitors (ACEIs) or
angiotensin II receptor blockers (ARBs) in reducing risk of cardiovascular events (CVEs) and …

Background Patients with type 2 diabetes and nephropathy have high cardiorenal morbidity
and mortality despite optimum treatment including angiotensin-converting enzyme (ACE) …

Background Hypertension develops early in patients with autosomal dominant polycystic
kidney disease (ADPKD) and is associated with disease progression. The renin …

Diabetic nephropathy is the most common cause of CKD and represents a large and
ominous public health problem. Patients with diabetic kidney disease have exceptionally …

The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
ADA's current clinical practice recommendations and is intended to provide the components …

Objective To examine the association between antihypertensive treatment and specific
adverse events. Design Systematic review and meta-analysis. Eligibility criteria Randomised …

Diabetic nephropathy (DN) is currently the leading cause of end-stage renal disease
globally. Given the increasing incidence of diabetes, many experts hold the view that DN will …